Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A4

    
• • ·Information for Readers

    Page :A5

    

• Curriculum in Cardiology

  • ·Vitamin D deficiency and coronary artery disease: A review of the evidence

    Page :283-291

    Vijay Kunadian, Gary A. Ford, Bilal Bawamia, Weiliang Qiu, JoAnn E. Manson

    Résumé Résumé Plan Plan

• Cardiac Safety Research Consortium

  • ·Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium

    Page :292-300

    Philip T. Sager, Gary Gintant, J. Rick Turner, Syril Pettit, Norman Stockbridge

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Rationale and design of Faith-based Approaches in the Treatment of Hypertension (FAITH), a lifestyle intervention targeting blood pressure control among black church members

    Page :301-307

    Kristie J. Lancaster, Antoinette M. Schoenthaler, Sara A. Midberry, Sheldon O. Watts, Matthew R. Nulty, Helen V. Cole, Elizabeth Ige, William Chaplin, Gbenga Ogedegbe

    Résumé Résumé Plan Plan  
  • ·The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: Rationale and design of the SYMPATHY trial

    Page :308

    Eva E. Vink, Esther de Beus, Rosa L. de Jager, Michiel Voskuil, Wilko Spiering, Evert-jan Vonken, G. Ardine de Wit, Kit C.B. Roes, Michiel L. Bots, Peter J. Blankestijn

    Résumé Résumé Plan Plan
  • ·Design and rationale of the TOTAL trial: A randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI

    Page :315

    Sanjit S. Jolly, John Cairns, Salim Yusuf, Brandi Meeks, Olga Shestakovska, Lehana Thabane, Kari Niemelä, Philippe Gabriel Steg, Olivier F. Bertrand, Sunil V. Rao, Alvaro Avezum, Warren J. Cantor, Samir B. Pancholy, Raul Moreno, Anthony Gershlick, Ravinay Bhindi, Robert C. Welsh, Asim N. Cheema, Shahar Lavi, Michael Rokoss, Vladimír Džavík

    Résumé Résumé Plan Plan
  • ·DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial

    Page :322-328

    Robin Hofmann, Stefan K. James, Leif Svensson, Nils Witt, Mats Frick, Bertil Lindahl, Ollie Östlund, Ulf Ekelund, David Erlinge, Johan Herlitz, Tomas Jernberg

    Résumé Résumé Plan Plan  
  • ·Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation

    Page :329-334

    Menno V. Huisman, Gregory Y.H. Lip, Hans C. Diener, Sergio J. Dubner, Jonathan L. Halperin, Chang S. Ma, Kenneth J. Rothman, Christine Teutsch, Kristina Zint, Diana Ackermann, Andreas Clemens, Dorothee B. Bartels

    Résumé Résumé Plan Plan  
  • ·The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study

    Page :335-341

    Alexander T. Cohen, Robert Harrington, Samuel Z. Goldhaber, Russell Hull, C. Michael Gibson, Adrian F. Hernandez, Michael M. Kitt, Todd J. Lorenz

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry

    Page :342

    Emily C. O’Brien, Matthew T. Roe, Elizabeth S. Fraulo, Eric D. Peterson, Christie M. Ballantyne, Jacques Genest, Samuel S. Gidding, Emma Hammond, Linda C. Hemphill, Lisa C. Hudgins, Iris Kindt, Patrick M. Moriarty, Joyce Ross, James A. Underberg, Karol Watson, Dave Pickhardt, Daniel J. Rader, Katherine Wilemon, Joshua W. Knowles

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Reperfusion times and in-hospital outcomes among patients with an isolated posterior myocardial infarction: Insights from the National Cardiovascular Data Registry (NCDR)

    Page :350-354

    Stephen W. Waldo, Daniel A. Brenner, Shuang Li, Karen Alexander, Peter Ganz

    Résumé Résumé Plan Plan
  • ·Hospital patterns of medical management strategy use for patients with non–ST-elevation myocardial infarction and 3-vessel or left main coronary artery disease

    Page :355

    Ralf E. Harskamp, Tracy Y. Wang, Deepak L. Bhatt, Stephen D. Wiviott, Ezra A. Amsterdam, Shuang Li, Laine Thomas, Robbert J. de Winter, Matthew T. Roe

    Résumé Résumé Plan Plan  
  • ·Changing prevalence, profile, and outcomes of patients with HIV undergoing cardiac surgery in the United States

    Page :363-368

    Antonio Polanco, Shinobu Itagaki, Yuting Chiang, Joanna Chikwe

    Résumé Résumé Plan Plan  
  • ·Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction

    Page :369

    Zubin J. Eapen, Melissa A. Greiner, Gregg C. Fonarow, Zhong Yuan, Roger M. Mills, Adrian F. Hernandez, Lesley H. Curtis

    Résumé Résumé Plan Plan  
  • ·Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: Evidence from the NCDR^®

    Page :376-383

    Judith H. Lichtman, Yongfei Wang, Sara B. Jones, Erica C. Leifheit-Limson, Leslee J. Shaw, Viola Vaccarino, John S. Rumsfeld, Harlan M. Krumholz, Jeptha P. Curtis

    Résumé Résumé Plan Plan  
  • ·The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry

    Page :384

    Kyung Woo Park, Jeehoon Kang, Si-Hyuck Kang, Hyo-Suk Ahn, Hyun-Jae Kang, Bon-Kwon Koo, In-Ho Chae, Tae-Jin Youn, Byung-Hee Oh, Young-Bae Park, David Kandzari, Hyo-Soo Kim

    Résumé Résumé Plan Plan  
  • ·Comparison of percutaneous coronary intervention for previously treated versus de novo culprit lesions in acute myocardial infarction patients: insights from the National Cardiovascular Data Registry

    Page :393

    Chee Tang Chin, John C. Messenger, David Dai, Lisa A. McCoy, Michael A. Kutcher, H. Vernon Anderson, Matthew T. Roe, Tracy Y. Wang

    Résumé Résumé Plan Plan  
  • ·Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: A meta-regression analysis of randomized trials

    Page :401

    Giuseppe Tarantini, Sorin Jakob Brener, Alberto Barioli, Andrea Gratta, Guido Parodi, Roberta Rossini, Eliano Pio Navarese, Giampaolo Niccoli, Anna Chiara Frigo, Giuseppe Musumeci, Sabino Iliceto, Gregg Whitney Stone

    Résumé Résumé Plan Plan  
  • ·Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in Native Americans

    Page :413-418

    Julie H. Oestreich, Lyle G. Best, Paul P. Dobesh

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Comment on: “A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis”

    Page :e9

    Fernando Alfonso, Amparo Benedicto, Teresa Bastante, Guillermo Diego, Fernando Rivero

    
  • ·Reply to Comment on: “A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis”

    Page :e11

    Seiji Habara, Kazuaki Mitsudo